Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients.

Overview of attention for article published in Clinical Laboratory, January 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,866 followers.

RT @Lymphoma_Papers: Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients #l…

18 Jan 2023

Reply Repost Favourite

Molecular Biomarker Exploration of Rituximab plus CHOP Therapy in Real-World Diffuse Large B-Cell Lymphoma Patients #lymphoma #lymsm https://t.co/meACQVIT9D

18 Jan 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.